57 results
Page 2 of 3
6-K
EX-99.1
y81qwhlsrvwn exh
26 Jan 22
Immunocore announces FDA approval of KIMMTRAK® (tebentafusp-tebn) for the treatment of unresectable or metastatic uveal melanoma
4:29pm
6-K
EX-99.1
22g 6jy25jr
7 Dec 21
Immunocore announces initial Phase 1 data of ImmTAC® candidate IMC-C103C targeting MAGE-A4
4:10pm
S-8
EX-99.2
4jtr ob1jns
12 Apr 21
Registration of securities for employees
4:02pm
S-8
EX-99.3
owd lki5kmbc
12 Apr 21
Registration of securities for employees
4:02pm
S-8
EX-99.4
6b83y3e4tdqr1tz0
12 Apr 21
Registration of securities for employees
4:02pm
S-8
EX-99.7
menc8erfne
12 Apr 21
Registration of securities for employees
4:02pm
S-8
EX-99.6
bh6zmg699rgl8dbrc
12 Apr 21
Registration of securities for employees
4:02pm
S-8
EX-99.1
r0wtdqvs
12 Apr 21
Registration of securities for employees
4:02pm
S-8
EX-99.5
n5hm65p4trrnzuw
12 Apr 21
Registration of securities for employees
4:02pm
S-8
EX-99.8
wen7xaom
12 Apr 21
Registration of securities for employees
4:02pm
20-F
EX-1.1
ahe9r
25 Mar 21
Annual report (foreign)
7:01am
20-F
EX-2.4
wy86jkl
25 Mar 21
Annual report (foreign)
7:01am
20-F
EX-4.20
hjjed8
25 Mar 21
Annual report (foreign)
7:01am
20-F
27lktk0eje86
25 Mar 21
Annual report (foreign)
7:01am
424B4
5tol45cpkc rh7x1yc
8 Feb 21
Prospectus supplement with pricing info
8:36am
F-1/A
21s2fsn7nr31suo3x
3 Feb 21
Registration statement (foreign) (amended)
5:22pm
F-1/A
0nx9jm 1ued8h
1 Feb 21
Registration statement (foreign) (amended)
6:21am
F-1/A
EX-3.1
rmz7oi8ngkergo8819
1 Feb 21
Registration statement (foreign) (amended)
6:21am
F-1/A
EX-10.3
r5kf6
1 Feb 21
Registration statement (foreign) (amended)
6:21am
F-1/A
EX-10.18
ciov n4kp6jdq2n
1 Feb 21
Registration statement (foreign) (amended)
6:21am